Rael, C. T., Das, D., Porter, J., Lopez-Ríos, J., Abascal, E., Dolezal, C., Vaughn, M. P., Giffenig, P., Lopez, J. M., Stonbraker, S., Sun, C., Velasco, R. A., Bitterfeld, L., Bockting, W. O., & Bauermeister, J. (2024). Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study. Journal of the Association of Nurses in AIDS Care, 35(5), 437–449. https://doi.org/10.1097/jnc.0000000000000488
Subjects:
Transgender Persons
(MeSH)
Qualitative Research
(MeSH)
Pre-Exposure Prophylaxis
(MeSH)
HIV Infections
(MeSH)
Health Personnel
(MeSH)
Anti-HIV Agents
(MeSH)
Pyridones
(MeSH)
Publication Type:
Article
Unique ID:
10.1097/jnc.0000000000000488
PMID:
Publication Date:
Data Source:
PubMed